THE IMPACT OF DISCOUNTING ON THE COST EFFECTIVENESS OF TISAGENLECLEUCEL FOR RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA

被引：0
|
作者：
Carey, N. [1 ]
Mccullagh, L. [1 ]
Barry, M. [1 ]
机构：
[1] Natl Ctr Pharmacoecon, Dublin, Ireland
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSB125
引用
收藏
页码：S85 / S86
页数：2
相关论文
共 50 条
  • [31] Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia
    Laetsch, Theodore W.
    Maude, Shannon L.
    Balduzzi, Adriana
    Rives, Susana
    Bittencourt, Henrique
    Boyer, Michael W.
    Buechner, Jochen
    De Moerloose, Barbara
    Qayed, Muna
    Phillips, Christine L.
    Pulsipher, Michael A.
    Hiramatsu, Hidefumi
    Tiwari, Ranjan
    Grupp, Stephan A.
    LEUKEMIA, 2022, 36 (06) : 1508 - 1515
  • [32] Tisagenlecleucel Manufacturing Feasibility in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Eldjerou, Lamis K.
    Acker, Christopher
    Howick, Damien
    Clough, Lee
    Fuchs, Miriam
    Salmon, Florence
    Willert, Jennifer
    Tiwari, Ranjan
    Pujols, Mayo
    Robson, Matthew
    BLOOD, 2019, 134
  • [33] CREBBP mutations in relapsed acute lymphoblastic leukaemia
    Charles G. Mullighan
    Jinghui Zhang
    Lawryn H. Kasper
    Stephanie Lerach
    Debbie Payne-Turner
    Letha A. Phillips
    Sue L. Heatley
    Linda Holmfeldt
    J. Racquel Collins-Underwood
    Jing Ma
    Kenneth H. Buetow
    Ching-Hon Pui
    Sharyn D. Baker
    Paul K. Brindle
    James R. Downing
    Nature, 2011, 471 : 235 - 239
  • [34] BREXUCABTAGENE AUTOLEUCEL FOR ADULT PATIENTS WITH REFRACTORY/RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA: COST-EFFECTIVENESS IN THE CLINICAL SUBSETS
    Marchetti, Monia
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 198 - 198
  • [35] Leukapheresis and Tisagenlecleucel Manufacturing Outcomes in Patients Age <3 Years with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Fong, David
    Tiwari, Ranjan
    Acker, Christopher
    Clough, Lee
    Willert, Jennifer
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (09): : 579.e1 - 579.e10
  • [36] CREBBP mutations in relapsed acute lymphoblastic leukaemia
    Mullighan, Charles G.
    Zhang, Jinghui
    Kasper, Lawryn H.
    Lerach, Stephanie
    Payne-Turner, Debbie
    Phillips, Letha A.
    Heatley, Sue L.
    Holmfeldt, Linda
    Collins-Underwood, J. Racquel
    Ma, Jing
    Buetow, Kenneth H.
    Pui, Ching-Hon
    Baker, Sharyn D.
    Brindle, Paul K.
    Downing, James R.
    NATURE, 2011, 471 (7337) : 235 - U127
  • [37] Cost-Effectiveness of Tisagenlecleucel in Paediatric Acute Lymphoblastic Leukaemia (pALL) and Adult Diffuse Large B-Cell Lymphoma (DLBCL) in Switzerland
    Maziar Moradi-Lakeh
    Mohsen Yaghoubi
    Patrick Seitz
    Mehdi Javanbakht
    Elisabeth Brock
    Advances in Therapy, 2021, 38 : 3427 - 3443
  • [38] Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia
    Theodore W. Laetsch
    Shannon L. Maude
    Adriana Balduzzi
    Susana Rives
    Henrique Bittencourt
    Michael W. Boyer
    Jochen Buechner
    Barbara De Moerloose
    Muna Qayed
    Christine L. Phillips
    Michael A. Pulsipher
    Hidefumi Hiramatsu
    Ranjan Tiwari
    Stephan A. Grupp
    Leukemia, 2022, 36 : 1508 - 1515
  • [39] Cost-Effectiveness of Tisagenlecleucel in Paediatric Acute Lymphoblastic Leukaemia (pALL) and Adult Diffuse Large B-Cell Lymphoma (DLBCL) in Switzerland
    Moradi-Lakeh, Maziar
    Yaghoubi, Mohsen
    Seitz, Patrick
    Javanbakht, Mehdi
    Brock, Elisabeth
    ADVANCES IN THERAPY, 2021, 38 (06) : 3427 - 3443
  • [40] Impact of tisagenlecleucel product attributes on clinical outcomes in pediatric and young adult patients with relapsed or refractory acute lymphoblastic leukemia (r/r ALL).
    Gershgorin, Irina
    Waldron, Edward R.
    Grupp, Stephan A.
    Levine, John E.
    Pulsipher, Michael A.
    Davies, Stella M.
    Myers, G. Doug
    Jeschke, Margit
    Engels, Boris
    del Corral, Chris
    Baruchel, Andre
    CANCER RESEARCH, 2021, 81 (13)
12345